Black Diamond Therapeutics, Inc. (BDTX)
$1.68-5.08%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $96M
- Beta
- 3.33
- P/E (TTM)
- -2.27
- Short % float
- 10.38%
- Days to cover
- 7.3
- SI change
- -7.2%
- 1W
- -6.67%
- 1M
- -17.24%
- vs SPY 1W
- -6.53%
- vs SPY 1M
- -19.75%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BDTX?
- LOPJLB’s latest quantitative signal on Black Diamond Therapeutics, Inc. (BDTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BDTX in?
- Black Diamond Therapeutics, Inc. (BDTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Black Diamond Therapeutics, Inc. (BDTX) do?
- Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal gro…